Drug Database
RE

recombinant human interferon alfa-2a

✓ Approved

BioGeneric Pharma · IFNAR2 · Recombinant Proteins

What is recombinant human interferon alfa-2a?

recombinant human interferon alfa-2a is a recombinant proteins developed by BioGeneric Pharma. It is approved for therapeutic indications via injectable (others).

Drug Profile

CompanyBioGeneric Pharma
Drug ClassRecombinant Proteins
Molecular TargetIFNAR2
RouteInjectable (Others)
StatusApproved
Sources: ClinicalTrials.gov, BioGeneric Pharma

Mechanism of Action

Molecular Targets

recombinant human interferon alfa-2a acts on 1 molecular target:

IFNAR2interferon alpha and beta receptor subunit 2 (IFNARB, IFN-alpha-REC)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

recombinant human interferon alfa-2a is developed for 2 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
Infections and infestationsHepatitis C✓ Approved
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Neoplasm malignant✓ Approved

Related Research Articles

PubMedToxicology in vitro : an international journal published in association with BIBRA2026-05-24

Cellular responses to morpholinated curcumin derivatives in human muscle-invasive bladder cancer cells.

Kobylka Paulina P, Murias Marek M, Bakun Pawel P, Goslinski Tomasz T et al.

Curcumin is a well-known compound with anticancer properties, as demonstrated in preclinical studies. However, its clinical potential is limited by several drawbacks. Medicinal chemistry, therefore, offers the opportunity to develop curcumin derivatives through structural modifications. This study showed cytotoxic activity of curcumin derivatives in muscle-invasive bladder cancer cells (HT-1376). Cytotoxicity was assessed under normoxic and hypoxic conditions and compared with effects on human primary bladder epithelial cells (BdEC). The most promising compounds (2a and 2a-B) were further investigated in a 3D cell culture model. Mechanistic studies included the evaluation of lactate dehydrogenase release, cell cycle distribution, and induction of apoptosis and necrosis using luminescent-, colorimetric-, and fluorescence-based assays. Furthermore, the intracellular uptake was investigated using flow cytometry and confocal microscopy. Tested compounds showed greater cytotoxicity than curcumin, with enhanced effects under hypoxic conditions. The derivatives containing a keto-enol moiety showed greater selectivity for bladder cancer cells than curcumin. Compounds 2a and 2a-B also showed greater cytotoxicity in the 3D cell culture model than curcumin. Compounds 2a and 2a-B altered cell cycle progression, increasing the population of cells in the G2/M and S phases, and induced apoptosis in a time- and concentration-dependent manner. Comparative analysis with previously reported data identifies compound 2a as a promising candidate for further investigation due to its high selectivity for malignant versus normal bladder epithelial cells.

PMID 42177000
Read full article →
PubMedBiotechnology letters2026-05-24

Genetic and phenotypic characterization of seedling drought tolerance in wheat with integrated analysis of trait variation and QTL mapping.

Zebarjad Aylin A, Sabouri Hossein H, Pezeshkian Zahra Z, Taliei Fakhtak F et al.

Wheat (Triticum aestivum L.) is a staple cereal crop highly vulnerable to drought stress, particularly during early seedling establishment, which limits productivity and yield stability. This study evaluated a recombinant inbred line population under well-watered and drought environments to dissect the morphological, physiological, and genetic bases of seedling drought tolerance. Drought stress severely reduced shoot and leaf biomass, while paradoxically enhancing root growth, suggesting adaptive resource reallocation to improve water foraging. Genetic variance analyses uncovered increased heritable variation for root traits under stress, alongside significant genotype-by-environment interactions, indicative of distinct adaptive responses. Multivariate analyses revealed an integrated stress-response network linking stay-gFreen phenotypes and biomass maintenance. Importantly, QTL mapping identified twelve drought-specific loci most notably on chromosomes 2A, 3B, 5A, and 6A as well as eight loci unique to non-stress conditions, underscoring environment-dependent genetic architectures. Major QTLs affecting seedling length, root length, and leaf senescence offer promising targets for marker-assisted breeding. Collectively, these results illuminate the complex, multigenic control of early-stage drought tolerance in wheat, providing a robust foundation for developing cultivars with improved resilience in water-limited environments and strengthening climate-smart breeding pipelines.

PMID 42176197
Read full article →
PubMedKidney international2026-05-24

Role of the Post-translational ISGylation of Interferon Regulatory Factor 9 in Diabetes-Induced Podocyte Injury.

Lv Zhimei Z, Hu Jinxiu J, Lang Yating Y, Fan Xiaoting X et al.

Diabetic kidney disease (DKD) is the most common cause of kidney failure, with podocyte injury being a key event in its progression. Here, by performing single-cell regulatory network inference and clustering analysis between DKD and normal kidney samples, we found a significant increase in interferon regulatory factor 9 (IRF9) transcriptional activity in the podocytes of DKD kidneys. However, the role of IRF9 in DKD remains poorly understood. Kidney tissue from patients with DKD and high glucose-cultured conditionally immortalized human podocyte cell line (HPC) were employed to investigate IRF9 expression and localization. RNA sequencing was performed to elucidate the role of IRF9 in podocyte injury. Co-immunoprecipitation, in-situ proximity ligation assay, and surface plasmon resonance were performed to confirm the binding between IRF9 and interferon-stimulated gene 15 (ISG15). ISGylation and ubiquitination assays were used to examine the potential effects of ISG15 on IRF9 expression. Podocyte-specific IRF9 deletion and overexpression mice and podocyte-specific ISG15 knockdown mice were established to assess kidney injury in vivo. IRF9 protein expression was increased in the podocytes of patients with DKD, without changes in IRF9 mRNA expression, and IRF9 expression was negatively correlated with eGFR and positively correlated with 24-hour urinary protein. In cultured human podocytes, high glucose conditions stimulated IRF9 protein expression without affecting IRF9 mRNA expression. Silencing IRF9 alleviated high glucose-induced podocyte injury, whereas IRF9 overexpression exacerbated podocyte injury. IRF9 induced podocyte injury via inflammasome activation and pyroptosis. Interestingly, high glucose exposure increased IRF9 protein expression by stimulating ISG15 expression, which promoted IRF9 ISGylation and subsequently inhibited IRF9 ubiquitination to increase IRF9 protein stability. In vivo, the podocyte-specific deletion of IRF9 or podocyte-specific knockdown of ISG15 attenuated podocyte and glomerular injury in streptozotocin-induced diabetic mice fed a high-fat diet; in contrast, the podocyte-specific overexpression of IRF9 exacerbated podocyte and glomerular injury in these diabetic mice. Targeting ISG15-IRF9 could be a potential novel therapy for podocyte injury in DKD.

PMID 42176776
Read full article →
PubMedThe protein journal2026-05-24

Cloning, Expression, Purification and Biochemical Characterization of Novel Thermostable Subtilisin-like Serine Protease from Thermococcus onnurineus NA1.

Jiddah Nafiu Usman NU, Ajingi Ya'u Sabo YS, Adam Abubakar Sunusi AS, Panbangred Watanalai W et al.

The persistent rise in demand for biocatalysts in industries has prompted the exploration of novel enzymes. Proteases are very important class of enzymes with many industrial applications. However, majority of the reported proteases are from mesophiles and exhibit low stability under harsh conditions limiting their potential applications. This study presents the expression and characterization of a novel thermostable recombinant subtilisin-like serine protease derived from Thermococcus onnurineus NA1. The subtilisin serine protease gene was successfully cloned and expressed in E. coli BL21. The recombinant protease was purified by affinity chromatography and has an estimated molecular mass of 29 kDa following SDS-PAGE analysis. It exhibited an optimal activity at a pH of 10 and temperature of 90 °C. The recombinant subtilisin-like serine protease maintained 96% of its activity at 100 °C. Additionally, Na+, Mg2+, Cu2+, and Mn2+ had minimal effect on the recombinant protease activity whereas the presence of Ca2+ significantly enhanced the enzyme activity. Interestingly, the recombinant protease was stable in the presence of different surfactants and inhibitors. These properties illustrate the potential of recombinant subtilisin-like serine protease for industrial applications.

PMID 42177730
Read full article →
PubMedAdvances in protein chemistry and structural biology2026-05-24

Transcriptomic profiling reveals immune pathway dysregulation and key interferon-responsive genes in Systemic Lupus Erythematosus.

Selvam Prasanna Kumar PK, Mohan Supraja S, Vasudevan Karthick K

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disorder characterized by chronic inflammation, multi-organ involvement, and a strong type I interferon (IFN) signature. To elucidate immune-specific molecular drivers of SLE, we performed transcriptomic profiling using RNA sequencing (RNA-seq) data from 117 samples (99 SLE patients, 18 healthy controls) obtained from the European Nucleotide Archive (PRJNA294187). Following quality control, alignment to GRCh38, and read quantification, differential expression analysis with DESeq2 identified 2150 differentially expressed genes (DEGs), including 1361 upregulated and 789 downregulated genes (FDR<0.01, |log₂FC=>1). Reactome pathway enrichment isolated 41 immune-related DEGs enriched in cytokine signaling, interferon response, antigen processing, and innate immune activation. Notably, interferon-stimulated genes (ISGs) such as EIF2AK2, ISG15, CXCL10, CXCL11, IFI44L, RSAD2, and HERC5 emerged as central nodes in immune regulatory networks. Gene Ontology analysis highlighted overactivation of defense response, chemokine-mediated cell trafficking, and Jak-STAT signaling pathways typically induced by viral infection but aberrantly sustained in SLE, driving chronic inflammation and autoimmunity. Several genes, including HERC5, HERC6, and IL5RA, exhibited regulatory roles in ubiquitination and cytokine receptor signaling, suggesting potential as biomarkers for disease activity. These findings support targeting type I IFN signaling and related immune circuits as therapeutic strategies, aligning with emerging clinical success of IFN-blockade in SLE. By prioritizing immune-focused DEGs and integrating pathway-level interpretation, our study refines the transcriptomic landscape of SLE and provides actionable molecular insights for precision medicine approaches aimed at disease modulation and patient stratification.

PMID 42177068
Read full article →
PubMedAdvances in protein chemistry and structural biology2026-05-24

Identification of common hub genes and pathways in systemic lupus erythematosus and cervical cancer using bioinformatics approach.

Loganathan Tamizhini T, Madhulekha S S, Zayed Hatem H, C George Priya Doss GPD

Systemic lupus erythematosus (SLE) is a complex autoimmune condition characterized by multifactorial pathogenesis involving dysregulated immune responses. It has been associated with an elevated risk of various cancers, notably cervical cancer (CC), one of the most common cancers in women globally. Despite this association, the molecular mechanisms linking SLE and CC remain incompletely defined. To investigate this intersection, we employed integrative bioinformatics approaches to analyze transcriptomic datasets relevant to both SLE and CC, including GSE112087, GSE154851, GSE46907, GSE49454, GSE50772, GSE63514, GSE64217, GSE63678, GSE7803, and GSE9750 . We performed differential gene expression analysis, constructed Protein-Protein Interaction (PPI) networks, and carried out functional annotation to pinpoint pivotal hub genes and signaling pathways implicated in both diseases. Our analysis revealed significant differentially expressed genes (DEGs) in SLE, predominantly associated with cytokine and interferon alpha/beta signaling pathways, as well as the innate immune response. Notable hub genes included MX1, ISG15, and STAT1. In CC, DEGs were chiefly enriched in the mitotic cell cycle and cytokine signaling processes, with CDK1 and DLGAP5 standing out as key hub genes. The cross-disease analysis identified shared DEGs between SLE and CC, particularly in the interferon-alpha/beta and cytokine signaling pathways. This suggests a shared molecular architecture that underlies both autoimmune and cancer pathogenesis. Our study underscores the common molecular pathways between SLE and CC, highlighting the significance of interferon and cytokine signaling in the pathogenesis of both diseases. These insights set the stage for future research into potential therapeutic targets for the treatment of both SLE and CC.

PMID 42177067
Read full article →

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about recombinant human interferon alfa-2a